News for DUSA Pharmaceuticals Inc - Google Finance

Celsus Therapeutics Strengthens Board of Directors With Addition of ...

Wed, 01 May 2013 12:13:10 GMT

Celsus Therapeutics Strengthens Board of Directors With Addition of ...
Marketwire (press release) - May 1, 2013

Most recently Bob served as President and Chief Executive Officer of DUSA Pharmaceuticals, Inc., a publicly traded specialty pharmaceutical and medical device company focused in the field of dermatology.

Hot stock: Morgan Stanley sees more upside in Sun Pharma

Mon, 13 May 2013 10:21:42 GMT

Hot stock: Morgan Stanley sees more upside in Sun Pharma
Economic Times - May 13, 2013

MUMBAI: Morgan Stanley has maintained 'Overweight' rating on Sun Pharmaceuticals but increased target price Rs 1,159 from Rs 845 and added the stock to "Asia Best Idea".

SMaRT Therapeutics Announces Appointment of Dr. John H. Abeles to the ...

Tue, 30 Apr 2013 12:33:22 GMT

SMaRT Therapeutics Announces Appointment of Dr. John H. Abeles to the ...
MarketWatch (press release) - Apr 30, 2013

I find the technology both fascinating and compelling as it could enable the company to avoid the obstacles that other RNA technologies like RNAi, antisense and microRNA have as of yet been unable to overcome.

Law Office of Brodsky & Smith, LLC Announces Investigation of DUSA Pharmaceuticals, Inc.

Wed, 14 Nov 2012 01:00:00 GMT

Law Office of Brodsky & Smith, LLC Announces Investigation of DUSA Pharmaceuticals, Inc.
Reuters Key Development - Nov 14, 2012

Law Office of Brodsky & Smith, LLC Announces Investigation Of Dusa Pharmaceuticals Inc

Sat, 10 Nov 2012 16:00:00 GMT

Law Office of Brodsky & Smith, LLC Announces Investigation Of Dusa Pharmaceuticals Inc
Reuters Key Development - Nov 10, 2012

WeissLaw LLP Investigates Dusa Pharmaceuticals Inc

Fri, 09 Nov 2012 23:25:00 GMT

WeissLaw LLP Investigates Dusa Pharmaceuticals Inc
Reuters Key Development - Nov 9, 2012

Faruqi & Faruqi, LLP Seeking More Cash For Shareholders Of Dusa Pharmaceuticals Inc

Fri, 09 Nov 2012 00:01:00 GMT

Faruqi & Faruqi, LLP Seeking More Cash For Shareholders Of Dusa Pharmaceuticals Inc
Reuters Key Development - Nov 9, 2012

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Dusa Pharmaceuticals Inc

Thu, 08 Nov 2012 21:04:00 GMT

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Dusa Pharmaceuticals Inc
Reuters Key Development - Nov 8, 2012

Dusa Pharmaceuticals Inc's Board of Directors Under Investigation For Potential Breaches Of Fiduciary Duty By Glancy Binkow & Goldberg LLP

Thu, 08 Nov 2012 18:29:00 GMT

Dusa Pharmaceuticals Inc's Board of Directors Under Investigation For Potential Breaches Of Fiduciary Duty By Glancy Binkow & Goldberg LLP
Reuters Key Development - Nov 8, 2012

Harwood Feffer LLP Announces Investigation of Dusa Pharmaceuticals Inc

Thu, 08 Nov 2012 17:57:00 GMT

Harwood Feffer LLP Announces Investigation of Dusa Pharmaceuticals Inc
Reuters Key Development - Nov 8, 2012